| Authors: |
Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rosenberger CL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Moore N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Foster JC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Naqash AR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Sharon E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Sullivan Coyne G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Schwartz GK; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH., Riedel RF; Duke Cancer Institute, Duke University Medical Center, Durham, NC., Glod J; Center for Cancer Research, National Cancer Institute, Bethesda, MD., Hu JS; Division of Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Conley AP; The University of Texas MD Anderson Cancer Center, Houston, TX., Read WL; Emory University, Atlanta, GA., Burgess MA; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA., Davis EJ; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Merriam P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Deshpande HA; Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT., Ladle BH; Department of Oncology, Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Okuno SH; Mayo Clinic, Rochester, MN., Beck JC; Division of Pediatric Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Chen JL; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH., Ferry-Galow KV; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Fino KK; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Miller BL; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Wilsker DF; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Begum A; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Parchment RE; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Center for Cancer Research, National Cancer Institute, Bethesda, MD. |
